(Q37853022)

24 August 2017

1 reference

title

Antithyroid drug-induced fetal goitrous hypothyroidism (English)

1 reference

24 August 2017

5

Ulla Feldt-Rasmussen

1 reference

24 August 2017

Sofie Bliddal

1

1 reference

24 August 2017

Ase Krogh Rasmussen

series ordinal

2

1 reference

24 August 2017

Karin Sundberg

series ordinal

3

1 reference

24 August 2017

Vibeke Brocks

series ordinal

4

1 reference

24 August 2017

publication date

15 March 2011

1 reference

Nature Reviews Endocrinology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

396-406

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.34

24 August 2017

exact match

0 references

cites work

Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Rapid resolution of fetal goiter associated with maternal Grave's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

What happens to the normal thyroid during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal and fetal thyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

The role of the placenta in thyroid hormone delivery to the fetus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Fetal and neonatal thyroid function: review and summary of significant new findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Thyroid hormone receptors in brain development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal thyroid hormones early in pregnancy and fetal brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Thyroid hormone action in the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

The immunology of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Efficacy of Oral Iodide Therapy on Neonatal Hyperthyroidism Caused by Maternal Graves’ Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Three-dimensional sonography in the evaluation and management of fetal goiter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Correct procedure in the presence of a fetal goiter associated with hypothyroidism. Observations from three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Fetal goiter and bilateral ovarian cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Successful intrauterine therapy for fetal goitrous hypothyroidism during late gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Non-invasive management of fetal goiter during maternal treatment of hyperthyroidism in Grave's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Intrauterine growth curves based on ultrasonically estimated foetal weights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

New intrauterine growth curves based on United States data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal thyroid disease and preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Autoimmune thyroid disease and pregnancy: relevance for the child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Management of hypo- and hyperthyroidism during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Thyroid hyperfunction during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Hyperthyroidism and pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Adverse effects of prenatal methimazole exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Treatment of hyperthyroidism in pregnancy and birth defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Liver transplantation for acute liver failure from drug induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Putting propylthiouracil in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

A case of methimazole-induced acute hepatic failure in a patient with chronic hepatitis B carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Immunity, thyroid function and pregnancy: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Diagnostic mid trimester amniocentesis: how safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Effect of Intraamniotic Fluid Thyroxine Injection on Fetal Serum and Amniotic Fluid Iodothyronine Concentrations*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Experience with intraamniotic thyroxine treatment in nonimmune fetal goitrous hypothyroidism in 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Successful in utero treatment of fetal goitrous hypothyroidism: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Children exposed in utero to propylthiouracil. Subsequent intellectual and physical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Gestational transient hyperthyroxinaemia (GTH): screening for thyroid function in 23,163 pregnant women using dried blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Ontogeny of the pituitary-thyroid system in fetal rats: observations on the fetal thyroid after maternal treatment with goitrogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Successful in utero treatment of fetal goiter and hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

In utero treatment of fetal goitrous hypothyroidism caused by maternal Graves' disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Prenatal treatment of fetal hypothyroidism: is there more than one option?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Antenatal diagnosis and treatment of fetal hypothyroidism. A report of two cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Intrauterine diagnosis and management of fetal goiter: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Sonographic findings in maternal hyperthyroidism. Fetal hyperthyroidism/fetal goiter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Color Doppler imaging of the thyroid gland in a fetus with congenital goiter: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Management of fetal thyroid goitres: a report of 11 cases in a single perinatal unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

The fetal thyroid: normal and abnormal sonographic measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal thyroid function during gestation is related to breech presentation at term

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

The Placental Transfer of Propylthiouracil, Methimazole and Carbimazole

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Methimazole in animal feed and congenital aplasia cutis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Treatment of Pregnant Patients with Basedow's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Sequential studies on thyroid antibodies during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

NEONATAL GOITER AFTER MATERNAL PROPYLTHIOURACIL THERAPY

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maternal compound W serial measurements for the management of fetal hypothyroidsm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Diagnosis and management of altered fetal thyroid status.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Intra-amniotic injection of thyroxine (T4Y to a human fetus. Evidence for conversion of T4 to reverse T3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.34

Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?

31 March 2020

1 reference

12 December 2020

[Fetal goiter with hypothyroidism. A case report]

1 reference

12 December 2020

Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole

1 reference

12 December 2020

Risk factors for developmental disorders in infants born to women with Graves disease

1 reference

12 December 2020

Methimazole embryopathy: delineation of the phenotype

1 reference

12 December 2020

Antenatal diagnosis and treatment of a fetal goiter

1 reference

12 December 2020

Unusual complications of antithyroid drug therapy: four case reports and review of literature

1 reference

12 December 2020

Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism

1 reference

12 December 2020

Methimazole and propylthiouracil equally cross the perfused human term placental lobule

1 reference

12 December 2020

Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism

1 reference

12 December 2020

[Treatment of maternal hyperthyroidism and fetal goiter]

1 reference

12 December 2020

Thyroid function and 3,3'-diiodothyronine sulfate cross-reactive substance (compound W) in maternal hyperthyroidism with antithyroid treatment

1 reference

12 December 2020

The management of Graves' disease during pregnancy

1 reference

12 December 2020

Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother, producing thyroid stimulating immunoglobulins

1 reference

12 December 2020

Type II and type III deiodinase activity in human placenta as a function of gestational age

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2011.34

1 reference

Dimensions Publication ID

24 August 2017

1029404717

0 references

1 reference